Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 1
1986 2
1987 3
1988 4
1989 2
1990 6
1991 9
1992 4
1993 1
1994 1
1995 3
1996 1
1997 4
1998 5
1999 2
2000 5
2001 2
2002 1
2003 3
2004 3
2005 5
2006 6
2007 6
2008 14
2009 8
2010 7
2011 4
2012 9
2013 19
2014 17
2015 9
2016 10
2017 5
2018 6
2019 9
2020 22
2021 13
Text availability
Article attribute
Article type
Publication date

Search Results

216 results
Results by year
Filters applied: . Clear all
Page 1
[High intensity interval training in teenagers].
Abarzúa V J, Viloff C W, Bahamondes V J, Olivera P Y, Poblete-Aro C, Herrera-Valenzuela T, Oliva C, García-Díaz DF. Abarzúa V J, et al. Among authors: oliva c. Rev Med Chil. 2019 Feb;147(2):221-230. doi: 10.4067/s0034-98872019000200221. Rev Med Chil. 2019. PMID: 31095171 Free article. Review. Spanish.
Radioresistance in Glioblastoma and the Development of Radiosensitizers.
Ali MY, Oliva CR, Noman ASM, Allen BG, Goswami PC, Zakharia Y, Monga V, Spitz DR, Buatti JM, Griguer CE. Ali MY, et al. Among authors: oliva cr. Cancers (Basel). 2020 Sep 3;12(9):2511. doi: 10.3390/cancers12092511. Cancers (Basel). 2020. PMID: 32899427 Free PMC article. Review.
Lapatinib plus capecitabine for HER2-positive advanced breast cancer.
Geyer CE, Forster J, Lindquist D, Chan S, Romieu CG, Pienkowski T, Jagiello-Gruszfeld A, Crown J, Chan A, Kaufman B, Skarlos D, Campone M, Davidson N, Berger M, Oliva C, Rubin SD, Stein S, Cameron D. Geyer CE, et al. Among authors: oliva c. N Engl J Med. 2006 Dec 28;355(26):2733-43. doi: 10.1056/NEJMoa064320. N Engl J Med. 2006. PMID: 17192538 Free article. Clinical Trial.
Trends in clinical development for PD-1/PD-L1 inhibitors.
Xin Yu J, Hodge JP, Oliva C, Neftelinov ST, Hubbard-Lucey VM, Tang J. Xin Yu J, et al. Among authors: oliva c. Nat Rev Drug Discov. 2020 Mar;19(3):163-164. doi: 10.1038/d41573-019-00182-w. Nat Rev Drug Discov. 2020. PMID: 32127660 No abstract available.
Combinations take centre stage in PD1/PDL1 inhibitor clinical trials.
Upadhaya S, Neftelino ST, Hodge JP, Oliva C, Campbell JR, Yu JX. Upadhaya S, et al. Among authors: oliva c. Nat Rev Drug Discov. 2021 Mar;20(3):168-169. doi: 10.1038/d41573-020-00204-y. Nat Rev Drug Discov. 2021. PMID: 33177720 Review. No abstract available.
Impact of COVID-19 on oncology clinical trials.
Upadhaya S, Yu JX, Oliva C, Hooton M, Hodge J, Hubbard-Lucey VM. Upadhaya S, et al. Among authors: oliva c. Nat Rev Drug Discov. 2020 Jun;19(6):376-377. doi: 10.1038/d41573-020-00093-1. Nat Rev Drug Discov. 2020. PMID: 32424343 No abstract available.
Evaluation of microvascular changes in the perifoveal vascular network using optical coherence tomography angiography (OCTA) in type I diabetes mellitus: a large scale prospective trial.
Zarranz-Ventura J, Barraso M, Alé-Chilet A, Hernandez T, Oliva C, Gascón J, Sala-Puigdollers A, Figueras-Roca M, Vinagre I, Ortega E, Esmatjes E, Adan A. Zarranz-Ventura J, et al. Among authors: oliva c. BMC Med Imaging. 2019 Nov 21;19(1):91. doi: 10.1186/s12880-019-0391-8. BMC Med Imaging. 2019. PMID: 31752726 Free PMC article. Clinical Trial.
Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.
Johnston S, Pippen J Jr, Pivot X, Lichinitser M, Sadeghi S, Dieras V, Gomez HL, Romieu G, Manikhas A, Kennedy MJ, Press MF, Maltzman J, Florance A, O'Rourke L, Oliva C, Stein S, Pegram M. Johnston S, et al. Among authors: oliva c. J Clin Oncol. 2009 Nov 20;27(33):5538-46. doi: 10.1200/JCO.2009.23.3734. Epub 2009 Sep 28. J Clin Oncol. 2009. PMID: 19786658 Clinical Trial.
216 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page